Evidence map›Paper›PMID 29968773›Full record

ArticleScientific reports2018

Phospholipase D1 regulation of TNF-alpha protects against responses to LPS.

Marc-Andre Urbahn, Sonja Charlotte Kaup, Friedrich Reusswig, Irena Krüger, Martina Spelleken, Kerstin Jurk, Meike Klier, Philipp A Lang, Margitta Elvers

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.1field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 19 citations in OpenAlex.

  1. sPLAScience advances · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Phospholipase D1 and D2 Synergistically Regulate Thrombus Formation.International journal of molecular sciences · 2020
    Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Marc-Andre UrbahnDepartment of Vascular and Endovascular Surgery, Heinrich-Heine-University University Medical Center, Moorenstraße.5, 40225, Düsseldorf, Germany.
Sonja Charlotte KaupDepartment of Vascular and Endovascular Surgery, Heinrich-Heine-University University Medical Center, Moorenstraße.5, 40225, Düsseldorf, Germany.
Friedrich ReusswigDepartment of Vascular and Endovascular Surgery, Heinrich-Heine-University University Medical Center, Moorenstraße.5, 40225, Düsseldorf, Germany.
Irena KrügerDepartment of Vascular and Endovascular Surgery, Heinrich-Heine-University University Medical Center, Moorenstraße.5, 40225, Düsseldorf, Germany.
Martina SpellekenDepartment of Vascular and Endovascular Surgery, Heinrich-Heine-University University Medical Center, Moorenstraße.5, 40225, Düsseldorf, Germany.
Kerstin JurkCenter for Thrombosis and Hemostasis (CTH), University Medical Center Mainz, Mainz, Germany.
Meike KlierDepartment of Vascular and Endovascular Surgery, Heinrich-Heine-University University Medical Center, Moorenstraße.5, 40225, Düsseldorf, Germany.
Philipp A LangDepartment of Molecular Medicine II, Heinrich Heine University, Düsseldorf, Germany.
Margitta ElversDepartment of Vascular and Endovascular Surgery, Heinrich-Heine-University University Medical Center, Moorenstraße.5, 40225, Düsseldorf, Germany. margitta.elvers@med.uni-duesseldorf.de.
Düsseldorf University Hospital · DEHeinrich Heine University Düsseldorf · DEUniversity Medical Center of the Johannes Gutenberg University Mainz · DE

Funding

Deutsche Forschungsgemeinschaft (German Research Foundation) 1116 (A05)Deutsche Forschungsgemeinschaft (German Research Foundation) 974/2 (A16)
6 · The paper itself

Abstract

Sepsis is a systemic inflammatory disorder with organ dysfunction and represents the leading cause of mortality in non-coronary intensive care units. A key player in septic shock is Tumor Necrosis Factor-alpha (TNF-α). Phospholipase (PL)D1 is involved in the regulation of TNF-α upon ischemia/reperfusion injury in mice. In this study we analyzed the impact of PLD1 in the regulation of TNF-α, inflammation and organ damage in experimental sepsis. PLD1 deficiency increased survival of mice and decreased vital organ damage after LPS injections. Decreased TNF-α plasma levels and reduced migration of leukocytes and platelets into lungs was associated with reduced apoptosis in lung and liver tissue of PLD1 deficient mice. PLD1 deficient platelets contribute to preserved outcome after LPS-induced sepsis because platelets exhibit an integrin activation defect suggesting reduced platelet activation in PLD1 deficient mice. Furthermore, reduced thrombin generation of PLD1 deficient platelets might be responsible for reduced fibrin formation in lungs suggesting reduced disseminated intravascular coagulation (DIC). The analysis of Pld1

Indexed as

AnimalsApoptosisBlood PlateletsCell MovementCells, CulturedDisease Models, AnimalFibrinImmunity, InnateInflammationLeukocytesLipopolysaccharidesMiceMice, Inbred C57BLMice, KnockoutNeutrophilsPhospholipase DFibrinLipopolysaccharidesPhospholipase Dphospholipase D1Tumor Necrosis Factor-alpha

Identifiers

PMID29968773
PMCPMC6030188
OpenAlexW2810886674

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.